Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 14
Pharmacogenomics and Personalized Medicine
- View all (495)
- Volume 15, 2022 (53)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Archive: Volume 14, 2021
Relationship Between KCNQ1 Polymorphism and Type 2 Diabetes Risk in Northwestern China
Xu J, Zhang W, Song W, Cui J, Tian Y, Chen H, Huang P, Yang S, Wang L, He X, Wang L, Shi B, Cui W
Pharmacogenomics and Personalized Medicine 2021, 14:1731-1751
Published Date: 31 December 2021
Systematic Pan-Cancer Analysis of KIF23 and a Prediction Model Based on KIF23 in Clear Cell Renal Cell Carcinoma (ccRCC)
Bai X, Cao Y, Yan X, Tuoheti K, Du G, Chen Z, Wu H, Guo L, Liu T
Pharmacogenomics and Personalized Medicine 2021, 14:1717-1729
Published Date: 30 December 2021
The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population [Corrigendum]
Zhang L, Li X, Lu J, Qian Y, Qian T, Wu X, Xu Q
Pharmacogenomics and Personalized Medicine 2021, 14:1715-1716
Published Date: 30 December 2021
ADAMTS8 Expression is a Potential Prognostic Biomarker for Postoperative Metastasis in Lymph Node-Negative Early-Stage Invasive Breast Carcinoma Patients
Li Y, Yang X, Sun J, Zhao Y, Zhou Q, Hua B
Pharmacogenomics and Personalized Medicine 2021, 14:1701-1713
Published Date: 30 December 2021
Fragile X Premutation: Medications, Therapy and Lifestyle Advice
Sodhi DK, Hagerman R
Pharmacogenomics and Personalized Medicine 2021, 14:1689-1699
Published Date: 29 December 2021
Isotretinoin Induced Hyperlipidemia and Impact of Leptin Gene rs 7799039 Polymorphism in Safety of Acne Patients
Mohamed AA, Hassnine A, Elsayed A, Montaser M, Ismail Y, El-Demery A, Sultan E, Abdel Aziz RS, Eldemiry E, Hagag R, El-Kholy AA, Salah E
Pharmacogenomics and Personalized Medicine 2021, 14:1679-1687
Published Date: 24 December 2021
PFN1 Gene Polymorphisms and the Bone Mineral Density Response to Alendronate Therapy in Postmenopausal Chinese Women with Low Bone Mass
Zhao J, Liu L, Lv S, Wang C, Yue H, Zhang Z
Pharmacogenomics and Personalized Medicine 2021, 14:1669-1678
Published Date: 23 December 2021
Combined GSTT1 Null, GSTM1 Null and XPD Lys/Lys Genetic Polymorphisms and Their Association with Increased Risk of Chronic Myeloid Leukemia
Abdalhabib EK, Jackson DE, Alzahrani B, Elfaki EM, Hamza A, Alanazi F, Ali EI, Algarni A, Ibrahim IK, Saboor M
Pharmacogenomics and Personalized Medicine 2021, 14:1661-1667
Published Date: 22 December 2021
Genetic Polymorphisms of Very Important Pharmacogene Variants in the Blang Population from Yunnan Province in China
Wang Y, Peng L, Lu H, Zhang Z, Xing S, Li D, He C, Jin T, Wang L
Pharmacogenomics and Personalized Medicine 2021, 14:1647-1660
Published Date: 17 December 2021
RF1 Gene Mutation in Familial Hemophagocytic Lymphohistiocytosis 2: A Family Report and Literature Review
Shi Y, Qiao Z, Bi X, Zhang C, Fu J, Jia Y, Yang G
Pharmacogenomics and Personalized Medicine 2021, 14:1637-1645
Published Date: 16 December 2021
Interleukin-16 rs4072111 Polymorphism is Associated with the Risk of Peri-Implantitis in the Chinese Population
Chen Z, Chen G
Pharmacogenomics and Personalized Medicine 2021, 14:1629-1635
Published Date: 15 December 2021
The Landscape of Clinical Implementation of Pharmacogenetic Testing in Central China: A Single-Center Study
Zhang J, Qi G, Han C, Zhou Y, Yang Y, Wang X, Liu S, Zhang X
Pharmacogenomics and Personalized Medicine 2021, 14:1619-1628
Published Date: 14 December 2021
Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature
White C, Scott RJ, Paul C, Ziolkowski A, Mossman D, Ackland S
Pharmacogenomics and Personalized Medicine 2021, 14:1603-1617
Published Date: 9 December 2021
FTO Gene Polymorphisms Contribute to the Predisposition and Radiotherapy Efficiency of Nasopharyngeal Carcinoma [Retraction]
Xiao F, Zhou J
Pharmacogenomics and Personalized Medicine 2021, 14:1601-1602
Published Date: 7 December 2021
Apolipoprotein E Gene Polymorphism and Coronary Artery Disease Risk Among Patients in Northwest China
Ma W, Ren X, Zhang L, Dong H, Lu X, Feng W
Pharmacogenomics and Personalized Medicine 2021, 14:1591-1599
Published Date: 7 December 2021
Identification of a Novel VPS13B Mutation in a Chinese Patient with Cohen Syndrome by Whole-Exome Sequencing
Hu X, Huang T, Liu Y, Zhang L, Zhu L, Peng X, Zhang S
Pharmacogenomics and Personalized Medicine 2021, 14:1583-1589
Published Date: 4 December 2021
MicroRNAs as Novel Biomarkers for P2Y12 – Inhibitors Resistance Prediction
Rytkin E, Mirzaev K, Bure I, Akmalova K, Abdullaev S, Kachanova A, Smirnov V, Grishina E, Lyakhova N, Aleshkovich E, Saribekian A, Andreev D, Shabunin A, Sychev D
Pharmacogenomics and Personalized Medicine 2021, 14:1575-1582
Published Date: 2 December 2021
Genetic Variant of PP2A Subunit Gene Confers an Increased Risk of Primary Liver Cancer in Chinese
Wang Y, Huang Q, Huang X, Zhao H, Guan B, Ban K, Zhu X, Ma Z, Tang Y, Su Z, Nong Q
Pharmacogenomics and Personalized Medicine 2021, 14:1565-1574
Published Date: 1 December 2021
Development and Validation of a Prognostic N6-Methyladenosine-Related Immune Gene Signature for Lung Adenocarcinoma
Zhang L, Luo Y, Cheng T, Chen J, Yang H, Wen X, Jiang Z, Li H, Pan C
Pharmacogenomics and Personalized Medicine 2021, 14:1549-1563
Published Date: 30 November 2021
Genetic Polymorphism of Drug Metabolic Gene CYPs, VKORC1, NAT2, DPYD and CHST3 of Five Ethnic Minorities in Heilongjiang Province, Northeast China
Zhang T, Li Q, Dong B, Liang X, Jia M, Bai J, Yu J, Fu S
Pharmacogenomics and Personalized Medicine 2021, 14:1537-1547
Published Date: 30 November 2021
Clinical Development of AKT Inhibitors and Associated Predictive Biomarkers to Guide Patient Treatment in Cancer Medicine
Coleman N, Moyers JT, Harbery A, Vivanco I, Yap TA
Pharmacogenomics and Personalized Medicine 2021, 14:1517-1535
Published Date: 25 November 2021
A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B
Li J, Chen H, Chen J, Zhou B, Hou J, Jiang DK
Pharmacogenomics and Personalized Medicine 2021, 14:1505-1515
Published Date: 23 November 2021
Prognostic Value of LHFPL Tetraspan Subfamily Member 6 (LHFPL6) in Gastric Cancer: A Study Based on Bioinformatics Analysis and Experimental Validation
Liu YJ, Yin SY, Zeng SH, Hu YD, Wang MQ, Huang P, Li JP
Pharmacogenomics and Personalized Medicine 2021, 14:1483-1504
Published Date: 20 November 2021
Association Between the Interferon-γ +874 T/A Polymorphism and the Risk and Clinical Manifestations of Systemic Lupus Erythematosus: A Preliminary Study
Liu S, Li J, Li Y, Liu Y, Wang K, Pan W
Pharmacogenomics and Personalized Medicine 2021, 14:1475-1482
Published Date: 19 November 2021
Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
Cheng F, Li Q, Wang J, Hu M, Zeng F, Wang Z, Zhang Y
Pharmacogenomics and Personalized Medicine 2021, 14:1463-1474
Published Date: 19 November 2021
The Help of HPV Integration Testing to Avoid the Misdiagnosis of a Patient with Stage Ia1 Cervical Cancer: A Case Report and Literature Review
Li J, Zhang X, Wang P, Li W
Pharmacogenomics and Personalized Medicine 2021, 14:1457-1461
Published Date: 18 November 2021
Pharmacogenomics and Personalized Medicine in Type 2 Diabetes Mellitus: Potential Implications for Clinical Practice
Venkatachalapathy P, Padhilahouse S, Sellappan M, Subramanian T, Kurian SJ, Miraj SS, Rao M, Raut AA, Kanwar RK, Singh J, Khadanga S, Mondithoka S, Munisamy M
Pharmacogenomics and Personalized Medicine 2021, 14:1441-1455
Published Date: 13 November 2021
ARNTL2 is a Prognostic Biomarker and Correlates with Immune Cell Infiltration in Triple-Negative Breast Cancer
Wang X, Li Y, Fu J, Zhou K, Wang T
Pharmacogenomics and Personalized Medicine 2021, 14:1425-1440
Published Date: 10 November 2021
Identification of Two Novel DNAAF2 Variants in Two Consanguineous Families with Primary Ciliary Dyskinesia
Lu C, Yang D, Lei C, Wang R, Guo T, Luo H
Pharmacogenomics and Personalized Medicine 2021, 14:1415-1423
Published Date: 10 November 2021
The Relevance of Regenerating Gene 1a Polymorphisms to Radiation Sensitivity and Survival of Nasopharyngeal Carcinoma Receiving Radiotherapy in a Southern Chinese Population
Xing HJ, Chen XD, Sun HX, Dai YZ, Han YF, Chen HB, Liu F
Pharmacogenomics and Personalized Medicine 2021, 14:1403-1413
Published Date: 6 November 2021
Variation of Genomic Sites Associated with Severe Covid-19 Across Populations: Global and National Patterns
Balanovsky O, Petrushenko V, Mirzaev K, Abdullaev S, Gorin I, Chernevskiy D, Agdzhoyan A, Balanovska E, Kryukov A, Temirbulatov I, Sychev D
Pharmacogenomics and Personalized Medicine 2021, 14:1391-1402
Published Date: 4 November 2021
Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole
Mafuru M, Wu S, Mayala H, Msengwa Z, Phillip A, Mgone C
Pharmacogenomics and Personalized Medicine 2021, 14:1379-1389
Published Date: 2 November 2021
Exploring the Epigenetic Regulatory Role of m6A-Associated SNPs in Type 2 Diabetes Pathogenesis
Chen M, Lin W, Yi J, Zhao Z
Pharmacogenomics and Personalized Medicine 2021, 14:1369-1378
Published Date: 27 October 2021
Pattern Recognition Molecules of Lectin Complement Pathway in Ischemic Stroke
Tsakanova G, Stepanyan A, Steffensen R, Soghoyan A, Jensenius JC, Arakelyan A
Pharmacogenomics and Personalized Medicine 2021, 14:1347-1368
Published Date: 21 October 2021
H/ACA snoRNP Gene Family as Diagnostic and Prognostic Biomarkers for Hepatocellular Carcinoma
Zhang M, Zhao W, Liu S, Liu H, Liu L, Peng Q, Du C, Jiang N
Pharmacogenomics and Personalized Medicine 2021, 14:1331-1345
Published Date: 19 October 2021
Pharmacokinetics of Tenofovir Alafenamide Fumarate and Tenofovir in the Chinese People: Effects of Non-Genetic Factors and Genetic Variations
Li X, Tan XY, Cui XJ, Yang M, Chen C, Chen XY
Pharmacogenomics and Personalized Medicine 2021, 14:1315-1329
Published Date: 14 October 2021
NUDT15 c.415C>T Polymorphism Predicts 6-MP Induced Early Myelotoxicity in Patients with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy
Pai AA, Mohan A, Benjamin ESB, Illangeswaran RSS, Xavier Raj I, Janet NB, Arunachalam AK, Kavitha ML, Kulkarni U, Devasia AJ, Fouzia NA, Abraham A, Srivastava A, George B, Mathews V, Korula A, Balasubramanian P
Pharmacogenomics and Personalized Medicine 2021, 14:1303-1313
Published Date: 2 October 2021
Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients
Park JE, Hong MJ, Lee SY, Lee JH, Choi JE, Kang HG, Do SK, Jeong JY, Shin KM, Lee WK, Choi SH, Lee YH, Seo HW, Yoo SS, Lee J, Cha SI, Kim CH, Park JY
Pharmacogenomics and Personalized Medicine 2021, 14:1291-1302
Published Date: 1 October 2021
Analysis of Very Important Pharmacogenomics Variants in the Chinese Lahu Population
Cheng Y, Li Q, Yang X, Ding H, Chen W, Dai R, Zhang C
Pharmacogenomics and Personalized Medicine 2021, 14:1275-1289
Published Date: 1 October 2021
miR-7, miR-10a and miR-143 Expression May Predict Response to Bevacizumab Plus Chemotherapy in Patients with Metastatic Colorectal Cancer
Romero-Lorca A, Novillo A, Gaibar M, Gilsanz MF, Galán M, Beltrán L, Antón B, Malón D, Moreno A, Fernández-Santander A
Pharmacogenomics and Personalized Medicine 2021, 14:1263-1273
Published Date: 29 September 2021
The Clinical Significance of miR-21 in Guiding Chemotherapy for Patients with Osteosarcoma
Li LZ, Wu ZZ, Lv Z
Pharmacogenomics and Personalized Medicine 2021, 14:1247-1261
Published Date: 29 September 2021
FTO Gene Polymorphisms Contribute to the Predisposition and Radiotherapy Efficiency of Nasopharyngeal Carcinoma
Xiao F, Zhou J
Pharmacogenomics and Personalized Medicine 2021, 14:1239-1245
Published Date: 28 September 2021
Influential Factors and Efficacy Analysis of Tacrolimus Concentration After Allogeneic Hematopoietic Stem Cell Transplantation in Children with β-Thalassemia Major
Li C, Lu J, Zhou S, Wei Y, Lv C, Liu T, Wu Y, Wu D, Qi J, Cai R
Pharmacogenomics and Personalized Medicine 2021, 14:1221-1237
Published Date: 24 September 2021
Associations Between Genetically Predicted Plasma N-Glycans and Prostate Cancer Risk: Analysis of Over 140,000 European Descendants
Liu D, Zhu J, Zhao T, Sharapov S, Tiys E, Wu L
Pharmacogenomics and Personalized Medicine 2021, 14:1211-1220
Published Date: 22 September 2021
Associations of GWAS-Identified Risk Loci with Progression, Efficacy and Toxicity of Radiotherapy of Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy
Li Q, Liang Y, Liu Z, Yu C
Pharmacogenomics and Personalized Medicine 2021, 14:1205-1210
Published Date: 21 September 2021
The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy
He J, Wang Z, Wang Y, Zou T, Li XP, Cao L, Chen J
Pharmacogenomics and Personalized Medicine 2021, 14:1193-1203
Published Date: 18 September 2021
The Effects of Gene Variations of GABRA2, GABRB1, GABRG2, GAD1 and SLC1A3 on Patients with Propofol During Anesthesia Induction
Zhang L, Zheng Z, Ma W, Zhang S, Xue F, Wang H, He Y, Ye F, Zhou S, Wen Y, Li X, Huang W, Huang M, Li J, Wang Z
Pharmacogenomics and Personalized Medicine 2021, 14:1185-1192
Published Date: 17 September 2021
Metabolic Processes are Potential Biological Processes Distinguishing Nonischemic Dilated Cardiomyopathy from Ischemic Cardiomyopathy: A Clue from Serum Proteomics
Huang G, Huang Z, Peng Y, Wang Y, Liu W, Xue Y, Yang W
Pharmacogenomics and Personalized Medicine 2021, 14:1169-1184
Published Date: 16 September 2021
DZIP1 Expression as a Prognostic Marker in Gastric Cancer: A Bioinformatics-Based Analysis
Liu YJ, Li JP, Zeng SH, Han M, Liu SL, Zou X
Pharmacogenomics and Personalized Medicine 2021, 14:1151-1168
Published Date: 16 September 2021
Genetic Polymorphism of GABRG2 rs211037 is Associated with Drug Response and Adverse Drug Reactions to Valproic Acid in Chinese Southern Children with Epilepsy
Lu J, Xia H, Li W, Shen X, Guo H, Zhang J, Fan X
Pharmacogenomics and Personalized Medicine 2021, 14:1141-1150
Published Date: 15 September 2021
Gephyrin and CYP2C9 Genetic Polymorphisms in Patients with Pharmacoresistant Epilepsy
El-Tallawy HN, Abuhamdah S, Nassar AY, Farghaly WMA, Saleem TH, Atta SA, Sayed AA, Tohamy AM, Hassan MH
Pharmacogenomics and Personalized Medicine 2021, 14:1133-1140
Published Date: 9 September 2021
Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients
Boiko AS, Pozhidaev IV, Paderina DZ, Bocharova AV, Mednova IA, Fedorenko OY, Kornetova EG, Loonen AJM, Semke AV, Bokhan NA, Ivanova SA
Pharmacogenomics and Personalized Medicine 2021, 14:1123-1131
Published Date: 7 September 2021
Smoking, Hypertension, and GG Genotype of the IL-6 rs1800796 Polymorphism are Independent Risk Factors for Abdominal Aortic Aneurysm in Han Population
Zhang Y, Xu G, Wang P
Pharmacogenomics and Personalized Medicine 2021, 14:1115-1121
Published Date: 7 September 2021
Incidence and Risk Factors of Lower-Extremity Deep Vein Thrombosis After Thrombolysis Among Patients with Acute Ischemic Stroke
Liu Z, Liu D, Guo ZN, Jin H, Sun T, Ni C, Yan X
Pharmacogenomics and Personalized Medicine 2021, 14:1107-1114
Published Date: 4 September 2021
Wuzhi Capsule Dosage Affects Tacrolimus Elimination in Adult Kidney Transplant Recipients, as Determined by a Population Pharmacokinetics Analysis
Chen L, Yang Y, Wang X, Wang C, Lin W, Jiao Z, Wang Z
Pharmacogenomics and Personalized Medicine 2021, 14:1093-1106
Published Date: 3 September 2021
Interactive Association Between CYP2C9 rs2860905 Polymorphism and Atrial Fibrillation on Ischemic Stroke in Taiwan Biobank Participants
Peng JW, Nfor ON, Ho CC, Hsu SY, Lung CC, Tantoh DM, Chou MC, Liaw YP
Pharmacogenomics and Personalized Medicine 2021, 14:1087-1092
Published Date: 31 August 2021
Association of Genetic Variants in miR-217 Gene with Risk of Coronary Artery Disease: A Case–Control Study
Han X, Liang X, Wu M, Zhang L, Jiang H
Pharmacogenomics and Personalized Medicine 2021, 14:1081-1086
Published Date: 28 August 2021
Genetic and Non-Genetic Factors Impact on INR Normalization in Preprocedural Warfarin Management
Eljilany I, Elarref M, Shallik N, Elzouki AN, Bader L, El-Bardissy A, Abdelsamad O, Al-Badriyeh D, Cavallari LH, Elewa H
Pharmacogenomics and Personalized Medicine 2021, 14:1069-1080
Published Date: 28 August 2021
Haematological Indicators of Response to Erythropoietin Therapy in Chronic Renal Failure Patients on Haemodialysis: Impact of Angiotensin-Converting Enzyme rs4343 Gene Polymorphism
Hamdan Almaeen A, Mostafa-Hedeab G
Pharmacogenomics and Personalized Medicine 2021, 14:1055-1068
Published Date: 27 August 2021
Genetic Polymorphisms of FCRL3, NLRP3 and IL2 are Associated with the Risk of Head and Neck Cancer in a Chinese Population
Zhang Y, Sun D
Pharmacogenomics and Personalized Medicine 2021, 14:1047-1053
Published Date: 26 August 2021
A Chinese Boy with Mowat–Wilson Syndrome Caused by a 10 bp Deletion in the ZEB2 Gene
Wei L, Han X, Li X, Han B, Nie W
Pharmacogenomics and Personalized Medicine 2021, 14:1041-1045
Published Date: 23 August 2021
Population Genetic Difference of Pharmacogenomic VIP Variants in the Tibetan Population
He C, Peng L, Xing S, Li D, Wang L, Jin T
Pharmacogenomics and Personalized Medicine 2021, 14:1027-1040
Published Date: 16 August 2021
Economic Impact of the Application of a Precision Medicine Model (5SPM) on Psychotic Patients
Carrascal-Laso L, Franco-Martín M, Marcos-Vadillo E, Ramos-Gallego I, García-Berrocal B, Mayor-Toranzo E, Sánchez-Iglesias S, Lorenzo C, Sevillano-Jiménez A, Sánchez-Martín A, García-Salgado MJ, Isidoro-García M
Pharmacogenomics and Personalized Medicine 2021, 14:1015-1025
Published Date: 16 August 2021
Long Non-Coding RNAs Gene Variants as Molecular Markers for Diabetic Retinopathy Risk and Response to Anti-VEGF Therapy
Mohammad HMF, Abdelghany AA, Al Ageeli E, Kattan SW, Hassan R, Toraih EA, Fawzy MS, Mokhtar N
Pharmacogenomics and Personalized Medicine 2021, 14:997-1014
Published Date: 14 August 2021
The Value of Population Screening in Advancing Personalized Medicine in the Field of Lung Cancer
Mogenet A, Greillier L, Tomasini P
Pharmacogenomics and Personalized Medicine 2021, 14:987-996
Published Date: 14 August 2021
Genetic Variation of Inflammatory Genes to Ischemic Stroke Risk in a Chinese Han Population
Zhang Z, Mei Y, Xiong M, Lu F, Zhao X, Zhu J, He B
Pharmacogenomics and Personalized Medicine 2021, 14:977-986
Published Date: 13 August 2021
Association Between Insomnia and Migraine Risk: A Case–Control and Bidirectional Mendelian Randomization Study
Chu S, Wu Z, Wu Z, Wu J, Qian Y
Pharmacogenomics and Personalized Medicine 2021, 14:971-976
Published Date: 13 August 2021
Case Report: Fatigue and Bleeding in a Polymedicated Patient Using Several Herbal Supplementations, Detected with g-Nomic® Software
Saldarreaga Marin A, Cendros M, Ciudad CJ, Sabater A
Pharmacogenomics and Personalized Medicine 2021, 14:963-970
Published Date: 12 August 2021
Individualized Drugs’ Selection by Evaluation of Drug Properties, Pharmacogenomics and Clinical Parameters: Performance of a Bioinformatic Tool Compared to a Clinically Established Counselling Process
Borro M, Gentile G, Preissner SH, Pomes LM, Gohlke BO, Del Casale A, Eckert A, Marchetti P, Preissner S, Preissner R, Simmaco M
Pharmacogenomics and Personalized Medicine 2021, 14:955-962
Published Date: 5 August 2021
Ovarian Sertoli-Leydig Cell Tumor, Multinodular Goiter, Cystic Nephromas and DICER1 Mutations: Case Report and Literature Review
Ni Y, Zhou X, Wu L, Wu P, Liu Y, Li Y, Cai L, Fu X, Zhang C
Pharmacogenomics and Personalized Medicine 2021, 14:947-953
Published Date: 3 August 2021
Prognostic Role and Potential Mechanisms of the Ferroptosis-Related Metabolic Gene Signature in Hepatocellular Carcinoma
Dai T, Li J, Lu X, Ye L, Yu H, Zhang L, Deng M, Zhu S, Liu W, Wang G, Yang Y
Pharmacogenomics and Personalized Medicine 2021, 14:927-945
Published Date: 3 August 2021
Influence of SULT1A1*2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients
Chamnanphon M, Sukprasong R, Gaedigk A, Manosuthi W, Chariyavilaskul P, Wittayalertpanya S, Koomdee N, Jantararoungtong T, Puangpetch A, Sukasem C
Pharmacogenomics and Personalized Medicine 2021, 14:915-926
Published Date: 24 July 2021
The Expression of miR-365 in Serum of Hypertension Patients with Left Ventricular Hypertrophy Was Up-Regulated, Which Was Positively Correlated with Left Ventricular Mass Index
Wu HB, Yang CS, Wang YC, Xie YT, Wang XC, Liu HL, Du RP
Pharmacogenomics and Personalized Medicine 2021, 14:905-913
Published Date: 21 July 2021
C5 Variant rs10985126 is Associated with Mortality in Patients with Symptomatic Coronary Artery Disease
Henes JK, Groga-Bada P, Schaeffeler E, Winter S, Hack L, Zdanyte M, Mueller K, Droppa M, Stimpfle F, Gawaz M, Langer H, Schwab M, Geisler T, Rath D
Pharmacogenomics and Personalized Medicine 2021, 14:893-903
Published Date: 21 July 2021
Genome-Wide Identification of m6A-Associated Single-Nucleotide Polymorphisms in Colorectal Cancer
Zhao H, Jiang J, Wang M, Xuan Z
Pharmacogenomics and Personalized Medicine 2021, 14:887-892
Published Date: 17 July 2021
Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing
Haga SB, Mills R, Moaddeb J, Liu Y, Voora D
Pharmacogenomics and Personalized Medicine 2021, 14:877-886
Published Date: 15 July 2021
Clinical Observation of Gene Polymorphism of Olanzapine or Aprepitant in Prevention of CINV
Jin Y, Jin G, Zhao J, Jiang C, Zhao L, Jiang Y, Chen F, Li H, Wang W, Wu Y, Liu G, Li X, Gu M, Li X, Li Q
Pharmacogenomics and Personalized Medicine 2021, 14:867-875
Published Date: 15 July 2021
IDUA Gene Variants and Response to Zoledronic Acid Treatment in Chinese Women with Postmenopausal Osteoporosis
Lin H, Li J, Xu Z, Liu T, Zhou X
Pharmacogenomics and Personalized Medicine 2021, 14:859-866
Published Date: 13 July 2021
Bioinformatics Analysis of Neuroblastoma miRNA Based on GEO Data
Shi J, Zhang P, Su H, Cai L, Zhao L, Zhou H
Pharmacogenomics and Personalized Medicine 2021, 14:849-858
Published Date: 13 July 2021
Interactive Association Between Intronic Polymorphism (rs10506151) of the LRRK2 Gene and Type 2 Diabetes on Neurodegenerative Diseases
Huang MH, Liu YF, Nfor ON, Hsu SY, Lin WY, Chang YS, Liaw YP
Pharmacogenomics and Personalized Medicine 2021, 14:839-847
Published Date: 13 July 2021
Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis
Ma Z, Wang X, Lv Q, Gong Y, Xia M, Zhuang L, Lu X, Yang Y, Zhang W, Fu G, Ye Y, Lai D
Pharmacogenomics and Personalized Medicine 2021, 14:823-837
Published Date: 12 July 2021
Single-Nucleotide Polymorphisms Related to Leprosy Risk and Clinical Phenotypes Among Chinese Population
Long SY, Wang L, Jiang HQ, Shi Y, Zhang WY, Xiong JS, Sun PW, Chen YQ, Mei YM, Pan C, Ge G, Wang ZZ, Wu ZW, Yu MW, Wang HS
Pharmacogenomics and Personalized Medicine 2021, 14:813-821
Published Date: 12 July 2021
Signature Panel of 11 Methylated mRNAs and 3 Methylated lncRNAs for Prediction of Recurrence-Free Survival in Prostate Cancer Patients
Cai J, Yang F, Chen X, Huang H, Miao B
Pharmacogenomics and Personalized Medicine 2021, 14:797-811
Published Date: 12 July 2021
Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting
Haga SB, Mills R, Moaddeb J, Liu Y, Voora D
Pharmacogenomics and Personalized Medicine 2021, 14:785-796
Published Date: 9 July 2021
Identification of Potential Key Genes and Regulatory Markers in Essential Thrombocythemia Through Integrated Bioinformatics Analysis and Clinical Validation
Wang J, Wu Y, Uddin MN, Chen R, Hao JP
Pharmacogenomics and Personalized Medicine 2021, 14:767-784
Published Date: 5 July 2021
Integrative DNA Methylation and Gene Expression Analysis of Cognitive Behavioral Therapy Response in Children and Adolescents with Obsessive-Compulsive Disorder; a Pilot Study
Rodriguez N, Martinez-Pinteño A, Blázquez A, Ortiz AE, Moreno E, Gassó P, Lafuente A, Lazaro L, Mas S
Pharmacogenomics and Personalized Medicine 2021, 14:757-766
Published Date: 29 June 2021
A Two-Stage Study Identifies Two Novel Polymorphisms in PRKAG2 Affecting Metformin Response in Chinese Type 2 Diabetes Patients
Xiao D, Liu JY, Zhang SM, Liu RR, Yin JY, Han XY, Li X, Zhang W, Chen XP, Zhou HH, Ji LN, Liu ZQ
Pharmacogenomics and Personalized Medicine 2021, 14:745-755
Published Date: 23 June 2021
Acetylator Status Among Newly Diagnosed and Recurrent Tuberculosis Patients from Kupang, Eastern Part of Indonesia
Sahiratmadja E, Rini IA, Penggoam S, Charles A, Maskoen AM, Parwati I
Pharmacogenomics and Personalized Medicine 2021, 14:737-744
Published Date: 22 June 2021
The Phenomenon of Gene Rearrangement is Frequently Associated with TP53 Mutations and Poor Disease-Free Survival in Hepatocellular Carcinoma
He F, Song K, Guan G, Huo J, Xin Y, Li T, Liu C, Zhu Q, Fan N, Guo Y, Wu L
Pharmacogenomics and Personalized Medicine 2021, 14:723-736
Published Date: 21 June 2021
Influence of SLCO1B1 521T>C, UGT2B7 802C>T and IMPDH1 −106G>A Genetic Polymorphisms on Mycophenolic Acid Levels and Adverse Reactions in Chinese Autoimmune Disease Patients
Shu Q, Fan Q, Hua B, Liu H, Wang S, Liu Y, Yao Y, Xie H, Ge W
Pharmacogenomics and Personalized Medicine 2021, 14:713-722
Published Date: 21 June 2021
A Functional Variant rs2072915 is Associated with the Susceptibility and Mortality of Cervical Squamous Cell Carcinoma
Li RL, Wu JH, Guo M, Sha LX, Xia SQ, Xu L
Pharmacogenomics and Personalized Medicine 2021, 14:705-712
Published Date: 16 June 2021
Mitochondrial Dynamics Related Genes -MFN1, MFN2 and DRP1 Polymorphisms are Associated with Risk of Lung Cancer
Liang X, Dang S
Pharmacogenomics and Personalized Medicine 2021, 14:695-703
Published Date: 14 June 2021
Identification of Independent and Communal Differentially Expressed Genes as Well as Potential Therapeutic Targets in Ischemic Heart Failure and Non-Ischemic Heart Failure
Wang Z, Zhang M, Xu Y, Gu Y, Song Y, Jiang T
Pharmacogenomics and Personalized Medicine 2021, 14:683-693
Published Date: 14 June 2021
Identification and Validation of Immune-Related lncRNA Signature as a Prognostic Model for Skin Cutaneous Melanoma
Ping S, Wang S, He J, Chen J
Pharmacogenomics and Personalized Medicine 2021, 14:667-681
Published Date: 3 June 2021
Physicians’ Knowledge and Attitudes Regarding Point-of-Care Pharmacogenetic Testing: A Hospital-Based Cross-Sectional Study
Muflih S, Alshogran OY, Al-Azzam S, Al-Taani G, Khader YS
Pharmacogenomics and Personalized Medicine 2021, 14:655-665
Published Date: 1 June 2021
Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
Svob Strac D, Konjevod M, Sagud M, Nikolac Perkovic M, Nedic Erjavec G, Vuic B, Simic G, Vukic V, Mimica N, Pivac N
Pharmacogenomics and Personalized Medicine 2021, 14:631-653
Published Date: 28 May 2021
Angiotensin System Polymorphisms’ in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study
Cafiero C, Rosapepe F, Palmirotta R, Re A, Ottaiano MP, Benincasa G, Perone R, Varriale E, D'Amato G, Cacciamani A, Micera A, Pisconti S
Pharmacogenomics and Personalized Medicine 2021, 14:621-629
Published Date: 27 May 2021
Ferroptosis-Related Gene Signature: A New Method for Personalized Risk Assessment in Patients with Diffuse Large B-Cell Lymphoma
Chen H, He Y, Pan T, Zeng R, Li Y, Chen S, Li Y, Xiao L, Zhou H
Pharmacogenomics and Personalized Medicine 2021, 14:609-619
Published Date: 26 May 2021
Association of HMGA2 Polymorphisms with Glioma Susceptibility in Chinese Children
Zhou J, Wang P, Zhang R, Huang X, Dai H, Yuan L, Ruan J
Pharmacogenomics and Personalized Medicine 2021, 14:601-607
Published Date: 25 May 2021
CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance
Qiao LY, Li HB, Zhang Y, Shen D, Liu P, Che YQ
Pharmacogenomics and Personalized Medicine 2021, 14:591-599
Published Date: 25 May 2021
Trigger-Specific Remodeling of KCa2 Potassium Channels in Models of Atrial Fibrillation
Rahm AK, Gramlich D, Wieder T, Müller ME, Schoeffel A, El Tahry FA, Most P, Heimberger T, Sandke S, Weis T, Ullrich ND, Korff T, Lugenbiel P, Katus HA, Thomas D
Pharmacogenomics and Personalized Medicine 2021, 14:579-590
Published Date: 20 May 2021
Pharmacogenomics in the United States Community Pharmacy Setting: The Clopidogrel-CYP2C19 Example
Kisor DF, Petry NJ, Bright DR
Pharmacogenomics and Personalized Medicine 2021, 14:569-577
Published Date: 18 May 2021
Genetic Variants, Circulating Level of MCP1 with Risk of Chronic Obstructive Pulmonary Disease: A Case-Control Study
Lin C, Wang Z, Shen L, Yi G, Li M, Li D
Pharmacogenomics and Personalized Medicine 2021, 14:561-567
Published Date: 11 May 2021
Circulating Level of Monocyte Chemoattractant Protein-1 and Risk of Coronary Artery Disease: A Case–Control and Mendelian Randomization Study
Li J, Zhang Y, Guo X, Wu Y, Huang R, Han X
Pharmacogenomics and Personalized Medicine 2021, 14:553-559
Published Date: 11 May 2021
Genetic Association Study Revealed Three Loci Were Associated Risk of Myopia Among Minors
Zhou Z, Li S, Yang Q, Yang X, Hao K, Liu Y, Xu S
Pharmacogenomics and Personalized Medicine 2021, 14:547-551
Published Date: 11 May 2021
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Response to Letter]
Takahashi PY, Ryu E, Cerhan JR, Bielinski SJ, Olson JE
Pharmacogenomics and Personalized Medicine 2021, 14:545-546
Published Date: 6 May 2021
BRCA2 3ʹ-UTR Polymorphism rs15869 Alters Susceptibility to Papillary Thyroid Carcinoma via Binding hsa-mir-1178-3p
Guo N, Qu P, Li H, Liu L, Jin H, Liu R, Zhang Z, Zhang X, Li Y, Lu X, Zhao Y
Pharmacogenomics and Personalized Medicine 2021, 14:533-544
Published Date: 6 May 2021
Digital PCR Detection of mtDNA/gDNA Ratio in Embryo Culture Medium for Prediction of Embryo Development Potential
Zhang Q, Ji H, Shi J, Wang L, Ding L, Jiang Y, Huang X, Qiu Snr P, Li P
Pharmacogenomics and Personalized Medicine 2021, 14:521-531
Published Date: 30 April 2021
Evaluation of CYP2C19 Gene Polymorphisms in Patients with Acid Peptic Disorders Treated with Esomeprazole
Díaz-Ordóñez L, Ramírez-Montaño D, Candelo E, González-Restrepo C, Silva-Peña S, Rojas CA, Sepulveda Copete M, Echavarria HR, Pachajoa H
Pharmacogenomics and Personalized Medicine 2021, 14:509-520
Published Date: 29 April 2021
Reversal of Chemotherapy Resistance to Cisplatin in NSCLC by miRNA-195-5p via Targeting the FGF2 Gene
Wang H, Sui Z, Wu X, Tang P, Zhang H, Yu Z
Pharmacogenomics and Personalized Medicine 2021, 14:497-508
Published Date: 28 April 2021
Towards a Clinical Efficacy Evaluation System Adapted for Personalized Medicine
Yuan B
Pharmacogenomics and Personalized Medicine 2021, 14:487-496
Published Date: 28 April 2021
The Impact of ABCB1 and CES1 Polymorphisms on Dabigatran Pharmacokinetics in Healthy Chinese Subjects
Liu Y, Yang C, Qi W, Pei Z, Xue W, Zhu H, Dong M, Guo Y, Cong D, Wang F
Pharmacogenomics and Personalized Medicine 2021, 14:477-485
Published Date: 23 April 2021
The EGFR Polymorphism Increased the Risk of Hepatocellular Carcinoma Through the miR-3196-Dependent Approach in Chinese Han Population
Zhang L, Li X, Lu J, Qian Y, Qian T, Wu X, Xu Q
Pharmacogenomics and Personalized Medicine 2021, 14:469-476
Published Date: 23 April 2021
DNA Methylation of Fluoxetine Response in Child and Adolescence: Preliminary Results
Martinez-Pinteño A, Rodriguez N, Blázquez A, Plana MT, Varela E, Gassó P, Lafuente A, Lazaro L, Mas S
Pharmacogenomics and Personalized Medicine 2021, 14:459-467
Published Date: 19 April 2021
CSF1R is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in the Gastric Cancer Microenvironment
Chen D, Xiong L, Zhang L, Yu H, Xu Y, Wang M, Jiang X, Xiong Z
Pharmacogenomics and Personalized Medicine 2021, 14:445-457
Published Date: 13 April 2021
Assessment of Weighted Gene Co-Expression Network Analysis to Explore Key Pathways and Novel Biomarkers in Muscular Dystrophy
Xu X, Hao Y, Wu J, Zhao J, Xiong S
Pharmacogenomics and Personalized Medicine 2021, 14:431-444
Published Date: 13 April 2021
CYP2C9*3/*3 Gene Expression Affects the Total and Free Concentrations of Valproic Acid in Pediatric Patients with Epilepsy
Wu X, Dong W, Li H, Yang X, Jin Y, Zhang Z, Jiang Y
Pharmacogenomics and Personalized Medicine 2021, 14:417-430
Published Date: 9 April 2021
Non-Classical 21-Hydroxylase Deficiency: Analysis of a Mutant Gene in a Uyghur Family and Literature Review
Maimaitiming J, Amuti G, TuHuTi A, Chen Y, Song XX, Wang J, Alimu A, Zhang K, Abudounaiyimu M, Jiang J, Wang XL, Guo YY
Pharmacogenomics and Personalized Medicine 2021, 14:409-416
Published Date: 7 April 2021
CHN1 is a Novel Prognostic Marker for Diffuse Large B-Cell Lymphoma
Sun J, Zhu X, Zhao Y, Zhou Q, Qi R, Liu H
Pharmacogenomics and Personalized Medicine 2021, 14:397-408
Published Date: 1 April 2021
Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum]
Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM
Pharmacogenomics and Personalized Medicine 2021, 14:395-396
Published Date: 31 March 2021
Correlation Study on HLA-DR and CD117 (c-Kit) Expressions: Its Prognosis and Treatment Response in Acute Myeloid Leukemia Patients
El-Meligui YM, Abd Elrhman HE, Salahuddin A, Hamouda MA, Kassem AB
Pharmacogenomics and Personalized Medicine 2021, 14:381-393
Published Date: 30 March 2021
Pathway to Ascertain the Role of Pharmacogenomics in Healthcare Utilization Outcomes [Letter]
Roman YM
Pharmacogenomics and Personalized Medicine 2021, 14:379-380
Published Date: 26 March 2021
Influence of UGT1A1 *6/*28 Polymorphisms on Irinotecan-Related Toxicity and Survival in Pediatric Patients with Relapsed/Refractory Solid Tumors Treated with the VIT Regimen
Zhu X, Zhu J, Sun F, Zhen Z, Zhou D, Lu S, Huang J, Que Y, Zhang L, Cai R, Wang J, Zhang Y
Pharmacogenomics and Personalized Medicine 2021, 14:369-377
Published Date: 23 March 2021
The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population
Wei Z, Yao M, Ning S, Wu Y, Zhou X, Zhong C, Yan K, Xie Y
Pharmacogenomics and Personalized Medicine 2021, 14:359-367
Published Date: 17 March 2021
Skeletal Abnormalities and VDR1 Gene Polymorphisms in Mucopolysaccharidosis Patients
Alkhzouz C, Cabau G, Lazea C, Asavoaie C, Bucerzan S, Mirea AM, Farcas M, Miclaus M Jnr, Popp R, Miclea D
Pharmacogenomics and Personalized Medicine 2021, 14:349-358
Published Date: 17 March 2021
Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana
Maseng MJ, Tawe L, Thami PK, Seatla KK, Moyo S, Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G, Gaseitsiwe S, Paganotti GM
Pharmacogenomics and Personalized Medicine 2021, 14:335-347
Published Date: 16 March 2021
Challenges Involved in Incorporating Personalised Treatment Plan as Routine Care of Patients with Diabetes
Unnikrishnan R, Radha V, Mohan V
Pharmacogenomics and Personalized Medicine 2021, 14:327-333
Published Date: 16 March 2021
Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus
Pasternak AL, Marshall VD, Gersch CL, Rae JM, Englesbe M, Park JM
Pharmacogenomics and Personalized Medicine 2021, 14:319-326
Published Date: 12 March 2021
Tackling Drug Resistance in EGFR Exon 20 Insertion Mutant Lung Cancer
Pacini L, Jenks AD, Vyse S, Wilding CP, Arthur A, Huang PH
Pharmacogenomics and Personalized Medicine 2021, 14:301-317
Published Date: 9 March 2021
Whole-Exome Sequencing in Patients Affected by Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Reveals New Variants Potentially Contributing to the Phenotype
Fonseca DJ, Morel A, Llinás-Caballero K, Bolívar-Salazar D, Laissue P
Pharmacogenomics and Personalized Medicine 2021, 14:287-299
Published Date: 1 March 2021
Enriching Medication Review with a Pharmacogenetic Profile – A Case of Tamoxifen Adverse Drug Reactions
Jeiziner C, Stäuble CK, Lampert ML, Hersberger KE, Meyer zu Schwabedissen HE
Pharmacogenomics and Personalized Medicine 2021, 14:279-286
Published Date: 19 February 2021
TSC2 Mutations Were Associated with the Early Recurrence of Patients with HCC Underwent Hepatectomy
Song K, He F, Xin Y, Guan G, Huo J, Zhu Q, Fan N, Guo Y, Zang Y, Wu L
Pharmacogenomics and Personalized Medicine 2021, 14:269-278
Published Date: 16 February 2021
Optimization of Busulfan Dosing Regimen in Pediatric Patients Using a Population Pharmacokinetic Model Incorporating GST Mutations
Yuan J, Sun N, Feng X, He H, Mei D, Zhu G, Zhao L
Pharmacogenomics and Personalized Medicine 2021, 14:253-268
Published Date: 15 February 2021
Relevance of PD-L1 Non-Coding Polymorphisms on the Prognosis of a Genetically Admixed NSCLC Cohort
Machado-Rugolo J, Gutierrez Prieto T, Fabro AT, Parra Cuentas ER, Sá VK, Baldavira CM, Rainho CA, Castelli EC, Farhat C, Takagaki TY, Nagai MA, Capelozzi VL
Pharmacogenomics and Personalized Medicine 2021, 14:239-252
Published Date: 15 February 2021
No Association Between Pharmacogenomics Variants and Hospital and Emergency Department Utilization: A Mayo Clinic Biobank Retrospective Study
Takahashi PY, Ryu E, Bielinski SJ, Hathcock M, Jenkins GD, Cerhan JR, Olson JE
Pharmacogenomics and Personalized Medicine 2021, 14:229-237
Published Date: 11 February 2021
Correlations Between TIMD-4 Gene Variants and the Risk and Clinical Features of Rheumatoid Arthritis in a Chinese Population
Yang Z, Liu S, Zhou L, Zhang H, Xu N
Pharmacogenomics and Personalized Medicine 2021, 14:221-228
Published Date: 9 February 2021
Identification of Crucial Genes and Pathways Associated with Atherosclerotic Plaque in Diabetic Patients
Li YY, Zhang S, Wang H, Zhang SX, Xu T, Chen SW, Zhang Y, Chen Y
Pharmacogenomics and Personalized Medicine 2021, 14:211-220
Published Date: 4 February 2021
TPMT Genetic Variability and Its Association with Hematotoxicity in Indonesian Children with Acute Lymphoblastic Leukemia in Maintenance Therapy
Rosdiana DS, Setiabudy R, Andalusia R, Gatot D, Louisa M, Bardosono S, Instiaty I
Pharmacogenomics and Personalized Medicine 2021, 14:199-210
Published Date: 3 February 2021
Association of CYP3A5 Gene Polymorphisms and Amlodipine-Induced Peripheral Edema in Chinese Han Patients with Essential Hypertension
Liang H, Zhang X, Ma Z, Sun Y, Shu C, Zhu Y, Zhang Y, Hu S, Fu X, Liu L
Pharmacogenomics and Personalized Medicine 2021, 14:189-197
Published Date: 2 February 2021
The Association Between Azathioprine Genetic Polymorphisms, Clinical Efficacy and Adverse Drug Reactions Among Egyptian Patients with Autoimmune Diseases
Abuelsoud N, Fayed H, Elkateeb E
Pharmacogenomics and Personalized Medicine 2021, 14:179-187
Published Date: 2 February 2021
Assessment of the Role of Selected SMAD3 and SMAD4 Genes Polymorphisms in the Development of Colorectal Cancer: Preliminary Research
Wosiak A, Wodziński D, Michalska K, Pietrzak J, Kordek R, Balcerczak E
Pharmacogenomics and Personalized Medicine 2021, 14:167-178
Published Date: 29 January 2021
Relationship Between Interleukin-6 −174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients
Sokolik R, Iwaszko M, Świerkot J, Wysoczańska B, Korman L, Wiland P, Bogunia-Kubik K
Pharmacogenomics and Personalized Medicine 2021, 14:157-166
Published Date: 28 January 2021
Genetic Polymorphism Effect on Warfarin–Rifampin Interaction: A Case Report and Review of Literature
Salem M, Eljilany I, El-Bardissy A, Elewa H
Pharmacogenomics and Personalized Medicine 2021, 14:149-156
Published Date: 26 January 2021
CYP2C9 Variations and Their Pharmacogenetic Implications Among Diverse South Asian Populations
Nizamuddin S, Dubey S, Singh S, Sharma S, Machha P, Thangaraj K
Pharmacogenomics and Personalized Medicine 2021, 14:135-147
Published Date: 27 January 2021
Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon
Fernandes MR, Rodrigues JCG, Maroñas O, Latorre-Pellicer A, Cruz R, Guerreiro JF, Burbano RMR, Assumpção PP, Ribeiro-dos-Santos A, Santos SEB, Carracedo A, Santos NPC
Pharmacogenomics and Personalized Medicine 2021, 14:117-133
Published Date: 22 January 2021
No Association Between FTO Gene Polymorphisms and Central Nervous System Tumor Susceptibility in Chinese Children
Liao Y, Yuan L, Zhang Z, Lin A, Zhou J, Zhuo Z, Zhao J
Pharmacogenomics and Personalized Medicine 2021, 14:109-115
Published Date: 19 January 2021
STAT6 rs324015 Gene Polymorphism Increases Ulcerative Colitis Risk: A Case–Control Study
Dai L, Zhang D, Qian Y, Wan Y, Chang S, Qian H
Pharmacogenomics and Personalized Medicine 2021, 14:101-107
Published Date: 19 January 2021
High LARGE1 Expression May Predict Benefit from Adjuvant Chemotherapy in Resected Non-Small-Cell Lung Cancer
Liu Y, Huang S, Kuang M, Wang H, Xie Q
Pharmacogenomics and Personalized Medicine 2021, 14:87-99
Published Date: 18 January 2021
Genetic Interaction of H19 and TGFBR1 Polymorphisms with Risk of Epilepsy in a Chinese Population
Zheng Z, Yan Y, Guo Q, Wang L, Han X, Liu S
Pharmacogenomics and Personalized Medicine 2021, 14:77-86
Published Date: 14 January 2021
Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions
Tong H, Phan NVT, Nguyen TT, Nguyen DV, Vo NS, Le L
Pharmacogenomics and Personalized Medicine 2021, 14:61-75
Published Date: 13 January 2021
Genetic Variants of the MIF Gene and Susceptibility of Rectal Cancer
Chuo D, Lin D, Yin M, Chen Y
Pharmacogenomics and Personalized Medicine 2021, 14:55-60
Published Date: 12 January 2021
The Prognostic Value of DNA Methylation, Post-Translational Modifications and Correlated with Immune Infiltrates in Gynecologic Cancers
Shang C, Li Y, Wu Z, Han Q, Zhu Y, He T, Guo H
Pharmacogenomics and Personalized Medicine 2021, 14:39-53
Published Date: 12 January 2021
Mitochondrial DNA in Fresh versus Frozen Embryo Culture Media of Polycystic Ovarian Syndrome Patients Undergoing Invitro Fertilization: A Possible Predictive Marker of a Successful Pregnancy
Sayed GA, Al-Sawaf HA, Al-Sawaf AH, Saeid M, Maged A, Ibrahim IH
Pharmacogenomics and Personalized Medicine 2021, 14:27-38
Published Date: 11 January 2021
Identification of Four Genes as Prognosis Signatures in Lung Adenocarcinoma Microenvironment
Yao Y, Zhang T, Qi L, Liu R, Liu G, Li J, Sun C
Pharmacogenomics and Personalized Medicine 2021, 14:15-26
Published Date: 8 January 2021
Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
Srisawasdi P, Rodcharoen P, Vanavanan S, Chittamma A, Sukasem C, Na nakorn C, Dejthevaporn C, Kroll MH
Pharmacogenomics and Personalized Medicine 2021, 14:1-13
Published Date: 6 January 2021